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Key Role of flt3 Ligand in Regulation
of the Common Lymphoid Progenitor but Not
in Maintenance of the Hematopoietic Stem Cell Pool
Russell, 1983; Kimura et al., 1998; Lyman and Jacobsen,
1998; Miller et al., 1996; Solar et al., 1998).
Experimental evidence support that the first commit-
ment step of multipotent HSC results in the segregation
into common myeloid and common lymphoid progeni-
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decisive separation into myeloid- and lymphoid-Sweden
restricted developmental pathways. Recently, the iden-2 The Granulocyte Research Laboratory
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ing them feasible to isolate prospectively (Akashi et al.,Rigshospitalet
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The fms-like tyrosine kinase-3 (flt3 or flk2) is like c-kit,
a cytokine tyrosine kinase receptor expressed primarily
in very early stages of hematopoiesis, including candi-
Summary date HSC (Lyman and Jacobsen, 1998; Matthews et
al., 1991; Rasko et al., 1995; Zeigler et al., 1994). Mice
The first lineage commitment step of hematopoietic deficient in expression of flk2 or flt3 ligand (FL) show
stem cells (HSC) results in separation into distinct deficient lymphopoiesis, preferentially affecting early B
lymphoid and myeloid differentiation pathways, re- cell development, but NK and dendritic cells are also
flected in the generation of common lymphoid and reduced (Mackarehtschian et al., 1995; McKenna et al.,
myeloid progenitors (CLP and CMP, respectively). In 2000). The preferential reduction in the earliest pro-B
this report we present the first evidence for a nonre- cells, as well as NK and dendritic cells in flk2- and FL-
dundant regulator of this process, in that adult mice deficient mice, could be due to FL being important for
deficient in expression of the flt3 ligand (FL) have se- differentiation of each of these lineages. Alternatively,
verely (10-fold) reduced levels of the CLP, accompa- flt3 and its ligand could be important for regulating the
nied by reductions in the earliest identifiable B and T generation, maintenance, or commitment of the CLP.
cell progenitors. In contrast, CMP and HSC are unaf- In principle, the HSC also represents such a common
fected in FL-deficient mice. Noteworthy, CLP express progenitor, but a reduction in HSC numbers affecting
high levels of both the flt3 receptor and ligand, indicat- lymphopoiesis could be expected to also affect myeloid
ing a potential autocrine role of FL in regulation of the development. However, myelopoiesis is normal in flk2-
earliest lymphoid commitment step from HSC. deficient mice (Mackarehtschian et al., 1995), and aside
from a slight overall reduction observed in BM (bone
marrow) cellularity, myelopoiesis is unaffected in FL-Introduction
deficient mice as well (McKenna et al., 2000).
Although flk2 was originally cloned based on its ex-All blood cell lineages arise from common hematopoietic
pression in the HSC compartment (Mackarehtschian etstem cells (HSC) (Morrison et al., 1995), which due to
al., 1995), recent studies have demonstrated that long-their self-renewal capacity can maintain hematopoiesis
term reconstituting HSC in mouse bone marrow lackthroughout the lifespan of an individual (Dick et al., 1985;
detectable cell surface flk2/flt3 expression (Adolfsson etJordan and Lemischka, 1990; Keller and Snodgrass,
al., 2001; Christensen and Weissman, 2001). This finding1990; Morrison et al., 1995; Osawa et al., 1996a; Smith
was unexpected, since a number of studies have sug-et al., 1991). The molecular mechanisms regulating HSC
gested that flk2/flt3 and its ligand might be importantfate decisions between self-renewal and lineage com-
regulators of the HSC pool. In particular, FL has beenmitment remain largely unknown (Domen and Weiss-
demonstrated to be very efficient at promoting ex vivo
man, 1999). Stem cell factor (or c-kit ligand, KL) and
expansion and retroviral transduction of murine and hu-
thrombopoietin (Tpo) have been shown to act directly
man candidate HSC, and is currently used extensively
on HSC (Ikuta and Weissman, 1992; Li and Johnson, for these purposes (Bryder and Jacobsen, 2000; Dao et
1994; Matsunaga et al., 1998; Sitnicka et al., 1996) al., 1997; Elwood et al., 1996; Lemieux et al., 1997; Ly-
through their corresponding receptors c-kit and c-mpl man and Jacobsen, 1998; Miller and Eaves, 1997; Petzer
(Ikuta and Weissman, 1992; McKinstry et al., 1997; et al., 1996; Piacibello et al., 1997; Yonemura et al.,
Okada et al., 1991; Solar et al., 1998), and studies of 1997). These seemingly contrasting findings could be
ligand and receptor-deficient mice have demonstrated explained either by HSC expressing low levels of flt3
that KL and Tpo play important nonredundant roles in (as suggested by expression of flt3 mRNA; Adolfsson
sustaining HSC numbers and/or function (Geissler and et al., 2001) or by FL regulating HSC through indirect
mechanisms. In further support of a potential role of FL
in HSC regulation, transplantation of flk2-deficient bone3 Correspondence: ewa.sitnicka@stemcell.lu.se
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Table 1. Reduced Ratios of Early Committed B and T Cell Progenitors in FL/ Mice
WT FL/
Tissue Population (% of total cells) (% of total cells) % of WT
Bone Marrow pro-B cells 3.3  2.6 0.54  0.14 16a
(B220CD43IgM)
pre-B cells 7.8  4.2 2.3  0.7 29a
(B220CD43IgM)
immature/mature B cells 2.6  0.5 1.7  0.45 65a
(B220CD43IgM)
Thymus pro-T cells 10.0  1.0 2.8  1.8 28a
(CD4CD8CD44CD25)
pre-T cells 26.5  2.7 31.4  2.6 118
(CD4CD8CD44CD25)
late pre-T cells 63.5  3.0 62.9  1.7 99
(CD4CD8CD44CD25)
Cells from bone marrow and thymus were isolated and stained with specific antibodies as described in the Experimental Procedures. All
analyses were performed in parallel for FL/ and WT cells. Data represent analysis of six age-matched mice of each genotype. Results are
presented as percent ( SD) of total cells, and the change in FL/ mice is compared to WT controls.
a Statistical significance, p  0.05.
marrow cells to wild-type recipient mice results in im- and Zlotnik, 1995), was found to be reduced by as much
as 72%, whereas the more mature CD8CD4CD44paired lymphoid as well as myeloid long-term reconsti-
tution (Mackarehtschian et al., 1995). However, it has (CD25and CD25) pre-T cells were present at normal
ratios (Table 1).not been established whether this is due to: (1) reduced
HSC numbers in flk2-deficient mice, (2) flk2/flt3 affecting The present finding that the earliest progenitors of the
B as well as T cell lineages are reduced in FL/ micethe immediate myeloid and lymphoid progeny of HSC,
or (3) a defect in HSC homing and engraftment following suggested that a common progenitor of these lineages
could be the primary target for flt3. Recently, a CLPtransplantation. Thus, definitive proof for a role of FL in
regulating the HSC pool in steady-state hematopoiesis has been identified in murine BM, defined by having a
LinIL-7RSca1lowkitlow phenotype (Kondo et al., 1997).is lacking.
Using FL-deficient rather than flk2-deficient mice, we Thus, the CLP represents the earliest stage of lymphoid-
restricted development, and the segregation into a CLPcould specifically address the role of FL in regulating
HSC, CLP, and CMP during steady-state hematopoiesis. and CMP (Akashi et al., 2000b) might represent the earli-
est known HSC commitment step (Akashi et al., 2000a).Whereas FL deficiency does not affect the frequency or
functional capacity of HSC or CMP, FL-deficient mice Therefore, we here investigated whether the CLP and
CMP compartments might be affected by the FL de-show striking reductions in CLP, suggesting an impor-
tant role for FL in promoting early lymphoid development letion.
First, we performed in vitro and in vivo studies con-through the generation of CLP from HSC.
firming that the CLP (LinIL-7RSca1lowkitlow ) popula-
tion had a lymphoid-restricted potential and that theResults
CMP (LinIL-7RSca1kitCD34Fclow) and granulo-
cyte-macrophage progenitors (GMP) (LinIL-7RSca1Severe Reductions in Common Lymphoid but Not
Common Myeloid Progenitors in FL-Deficient Mice kit CD34 Fchigh) were myeloid restricted (Table 2).
Strikingly, the frequency of CLP was reduced by asMice lacking expression of flk2 or FL have been demon-
strated to have reduced numbers of early B lymphoid much as 10-fold in BM of FL/ mice when compared
to the WT controls (0.0034  0.0028% and 0.032 progenitors (Mackarehtschian et al., 1995; McKenna et
al., 2000). This finding was confirmed in the present 0.014%, respectively, n  6, p  0.01) (Figure 1A). In
contrast, the frequency of CMP was only marginallystudies, with preferential reductions in BM pro-B
(B220CD43IgM) and pre-B (B220CD43IgM) cells reduced in FL/ mice (0.13 0.04% and 0.09 0.02%,
for WT and FL/ mice, respectively, n  6, p  0.05)(Table 1). Not previously reported, we found that this
also translated into a slight but significant reduction in (Figure 1B), and GMP and megakaryocyte-erythroid pro-
genitors (MEP) were not significantly affected. Thus,peripheral blood (PB) B cells (33  11% in FL/ mice,
54  8% WT control, n  24, p  0.01) comparable mice deficient in FL have severely reduced CLP but
normal frequencies of CMP.to the reductions in mature and immature B cells
(B220CD43IgM) in BM (Table 1). The reduced ability to generate CLP in the absence
of FL was partially recapitulated when transplanting WTMature T cell levels are normal in flk2- and FL-deficient
mice and double-negative (DN) CD4CD8 thymocytes bone marrow cells into lethally irradiated FL/ mice
(see Experimental Procedures for details). Donor-derivedare present at normal frequencies (Mackarehtschian et
al., 1995; McKenna et al., 2000). However, a more de- reconstitution of LinIL-7RSca1kitCD34Fclow
CMP was comparable in FL/ and WT mice (0.103 tailed analysis of subsets of DN thymocytes had not
previously been done. Performing such an analysis in 0.070% and 0.129  0.070%, respectively, n  6, p 
0.98). In contrast, a consistent 50% reduction in forma-FL-deficient mice, the frequency of the earliest commit-
ted T cell progenitors, CD4CD8CD44CD25 pro-T tion of LinIL-7RSca1lowkitlow CLP was observed in
FL/ recipients when compared to WT recipientscells (Akashi et al., 2000a; Godfrey et al., 1993; Moore
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Table 2. In Vitro and In Vivo Lineage-Restricted Potentials of Purified CLP, CMP, and GMP
In Vitro In Vivo
Growth Fold % B Cells % Myeloid Cells % B Cells % Myeloid Cells
Cells Factors Expansion (B220 CD19) (Mac-1/Gr-1 B220) Tissue (B220 Mac-1/Gr-1) (Mac-1/Gr-1 B220)
CLP lymphoid 3533 99.1 0 BM 84.6 0
CLP myeloid 0 0 0 spleen 54.4 0
CMP lymphoid 7.4 0 92.3 BM 0 54.1
CMP myeloid 2233 0 94.7 spleen 2.2 81.7
GMP lymphoid 5.4 0 83.4 not done
GMP myeloid 1149 0 96.6 not done
CLP, CMP, and GMP were isolated from CD45.1 mice, and 50–500 cells were cultured for 11 days under myeloid (GM-CSFG-CSFIL-
3KLTpoEpoCSF-1) or lymphoid (KLFLIL-7) conditions (see Experimental Procedures). In vitro megakaryocytic potential was also
evaluated and was detected only in CMP cultured under myeloid conditions but not in GMP or CLP (data not shown).
For in vivo analysis, lethally irradiated CD45.2 recipient mice were transplanted with 1000 sorted CLP or CMP from CD45.1 donor mice. Seven
days after transplantation, the proportion of B and myeloid cells in the donor-derived (CD45.1) fraction was determined by flow cytometry
(Experimental Procedures). This early time point was chosen due to the short half-life of myeloid precursors (Akashi et al., 2000b). T cell
development from CLP cannot be observed at this time point (Kondo et al., 1997) but was observed 4–6 weeks following transplantation with
CLP (D.B. et al., unpublished data). All data (in vitro and in vivo) are presented as mean values from two to three experiments. In each in vivo
experiment two to three mice were analyzed in each experimental group.
(0.0110  0.005% and 0.0208  0.009%, n  6, p  restrictive role of FL in steady-state hematopoiesis.
However, previous studies had also implicated FL as0.05).
a possible key regulator of the HSC pool (Bryder and
Jacobsen, 2000; Dao et al., 1997; Elwood et al., 1996;FL-Deficient Mice Have Normal Levels of
Phenotypically and Functionally Defined HSC Lemieux et al., 1997; Lyman and Jacobsen, 1998; Mac-
karehtschian et al., 1995; Miller and Eaves, 1997; PetzerA selective and dramatic reduction in CLP but not CMP
would be best compatible with an early and lymphoid- et al., 1996; Piacibello et al., 1997; Yonemura et al.,
Figure 1. FL-Deficient Mice Have Severe Re-
ductions in CLP but Normal Levels of CMP
and HSC
BM cells from WT control and FL/ mice
were stained with antilineage cocktail to-
gether with antibodies against Sca-1, c-kit,
CD34, IL-7R, and anti-Fc (Experimental
Procedures).
(A) Frequency of CLP defined by the LinIL-
7RSca1lowkitlow phenotype (indicated by the
box).
(B) Frequency of CMP defined by the LinIL-
7RSca1kitCD34Fclow phenotype (indi-
cated by the lower right box). The upper right
box defines the granulocyte-macrophage
progenitors (GMP), and the lower left box in-
dicates common megakaryocytic-erythroid
progenitors (MEP) as previously described
(Akashi et al., 2000b).
(C) Frequency of cells within LinSca1kit
HSC pool (indicated by the box).
(D) CD34 expression within LinSca1kit
cell population (the bar indicates isotype con-
trol). All mice investigated were 10–14 weeks
old and age matched. Six control and six
FL/ mice were analyzed individually. Plots
show representative analysis from control
and FL/ mouse.
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Figure 2. FL-Deficient Mice Have Normal Levels and Activity of Long-Term Multilineage Repopulating HSC
Lethally irradiated WT CD45.1 recipient mice were transplanted with 1  106 BM cells from CD45.2 WT (white bars) or FL/ mice (black bars)
in competition with 1  106 CD45.1 WT cells.
(A) Donor (CD45.2) cell reconstitution in PB 16 weeks after transplantation.
(B) Donor (CD45.2) cell reconstitution in BM 18 weeks after transplantation.
(C) Donor (CD45.2) cell reconstitution in PB 12 weeks after secondary transplantation. Eighteen weeks posttransplantation, BM cells were
pooled from primary recipients and transplanted (one femur equivalent) into lethally irradiated secondary recipients.
(D) Donor (CD45.2) cell reconstitution in BM 12 weeks after secondary transplantation. All lineage data are expressed as percent donor
reconstitution in relation to all cells (CD45.1CD45.2) in tissue indicated.
(E) Total CD45.2 cellularity and LSK numbers in BM 18 weeks after transplantation in primary recipients.
(F) Total CD45.2 cellularity and LSK numbers in BM 12 weeks after secondary transplantation.
Data in (E) and (F) are expressed as total number of cells per two tibiae and two femora (mean  SD). BM cells after secondary transplantation
were pooled for analysis. All data presented are mean values ( SD) of ten mice in each group from two replicate experiments.
1997), although direct evidence for a role of FL in HSC lineage reconstituting activity (Ikuta and Weissman,
1992; Li and Johnson, 1995; Okada et al., 1991; Osawaregulation in steady-state hematopoiesis is lacking. Ac-
cess to FL/ (rather than flt3/) mice allowed us to et al., 1996b; Spangrude et al., 1988). The frequency of
cells with a LSK phenotype was the same in FL-deficientdirectly address this by evaluating FL/ HSC function
in wild-type recipients. as in wild-type control mice (0.21  0.06% and 0.22 
0.07%, respectively, n 6, p 0.84) (Figure 1C). RecentThe LinSca1kit (LSK) compartment in steady-state
hematopoiesis contains most, if not all, long-term multi- studies have demonstrated that LSK cells lacking CD34
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Table 3. FL but Not KL Promotes In Vitro Survival of CLP
CLP CMP
Fold % Cells with
Preincubation Expansion % Gr-1 % B220 CD19 Preincubation Myeloid Potential
None 762 0 97.1 None 99.4
(freshly sorted cells) (freshly sorted cells)
40 hr 0 0 0 6 days 0.6
medium medium
40 hr 0 0 0 6 days 53.8
KL KL
40 hr 1236 0 93.4 6 days 13.8
FL FL
Fifty to one hundred sorted CLP were preincubated in medium alone, FL, or KL for 40 hr before KLFLIL-7 were added to promote
proliferation and B cell differentiation of CLP that potentially survived the preincubation period. Following an additional 11 days of culture,
cell numbers were established, and cell surface phenotypes were analyzed by FACS (Experimental Procedures). Freshly isolated CLP cultured
directly in KLFLIL-7 without any preincubation served as a control. Data shown are from one representative experiment out of two giving
similar results. Sorted CMP were seeded in Terasaki plates at a density of one cell per well in medium alone, FL, or KL. After 6 days of
preincubation, GM-CSFG-CSFIL-3KLTpoEpoCSF-1 were added to all the wells to promote myeloid development of surviving CMP.
The number of proliferating clones and myeloid differentiation were evaluated 12 days later (Experimental Procedures). Freshly isolated CMP
cultured for 12 days with the same cytokine cocktail without any preincubation served as controls. One hundred and twenty wells were
analyzed per group in each experiment. Results are expressed as the percentage of cells forming myeloid colonies in the different groups.
Data represent mean values from two experiments.
expression represent a virtually pure HSC population in frequency and reconstituting activity of HSC in BM of
FL-deficient mice are normal. To assess this more rigor-the BM of adult mice (Ito et al., 2000; Osawa et al.,
1996a). Importantly, the fraction of CD34 cells within ously and to also address HSC self-renewal capacity,
BM cells from primary recipients of FL/ and WT cellsthe LSK compartment was almost identical in the BM
of FL/ and WT mice (0.053  0.005% and 0.049  were transplanted into secondary recipients 18 weeks
following the initial transplantation (see Experimental0.007%, respectively, n  6, p  0.1) (Figure 1D).
Although the phenotypic analysis suggested that the Procedures for details). Three months following the sec-
ondary transplantation, FL/ and WT cells showed anHSC pool was not affected in FL-deficient mice, the
level and functional capacity of long-term repopulating indistinguishable ability to reconstitute PB and BM both
with regard to total reconstitution and lineage distribu-HSC can only be reliably determined through in vivo
long-term reconstitution studies (Domen and Weiss- tion (Figures 2C and 2D). The BM of primary and second-
ary recipients was also investigated for contribution ofman, 1999). Thus, lethally irradiated WT recipients
(CD45.1) were transplanted with 1  106 BM cells from FL/ and WT cells to maintenance of cells with a LSK
HSC phenotype, and again no difference could be ob-either FL/ or WT mice (both CD45.2) in competition
with 1 106 CD45.1 (recipient) WT BM cells (see Experi- served (Figures 2E and 2F). Thus, the HSC compartment
appears to be unaffected in FL-deficient mice with re-mental Procedures for details). Sixteen weeks following
transplantation, the contribution of FL/-derived cells gard to HSC numbers, as well as reconstituting and self-
renewal capacity following transplantation.to overall PB reconstitution was not significantly differ-
ent from that of mice transplanted with WT control cells
(51  8% and 61  13%, respectively, n  10) (Figure FL but Not KL Promotes CLP Survival In Vitro
Cytokines have been suggested to promote lineage de-2A). Furthermore, the contribution of FL/ and WT cells
to PB reconstitution of B, T, and myeloid cells did not velopment in a permissive manner by promoting cell
survival (Akashi et al., 1997; Lagasse and Weissman,differ significantly (Figure 2A), with the exception that
FL/ cells contributed slightly less to B cell reconstitu- 1997; Maraskovsky et al., 1997). In that regard, both KL
and FL have been shown to be potent viability factors fortion (32  6%, compared to 43  9% in WT controls,
percent of total cellularity, n  10, p  0.05) (Figure 2A). primitive hematopoietic progenitors (Keller et al., 1995;
Veiby et al., 1996), and we recently demonstrated that KLThis could be due to the fact that FL- and flk2-deficient
mice have reduced levels of B cell progenitors that might but not FL promotes survival of long-term repopulating
HSC (Adolfsson et al., 2001). To address, whether thecontribute to B cell reconstitution in PB at this time
(Mackarehtschian et al., 1995; McKenna et al., 2000). nonredundant role of FL in regulating CLP might poten-
tially be mediated through its ability to promote theirMost importantly, myeloid cell reconstitution, which rep-
resents the best measure of stem cell activity due to survival, sorted CLP were cultured in medium alone, FL,
or KL. Following 40 hr in medium alone, no CLP couldtheir short half-life, was not different in FL/ and WT
cells (5.5  1.3% and 4.6  1.3%, respectively, percent be recovered, whereas the B cell potential of CLP cul-
tured in FL was comparable to that of freshly isolatedof total PB cellularity, n  10, p  0.3) (Figure 2A).
Reconstitution analysis was also performed in the BM cells (Table 3). In contrast, no CLP survived in the pres-
ence of KL. This pattern was in striking contrast to thatat 18 weeks after transplantation, and no difference was
observed between WT and FL/ contribution to total observed for primitive myeloid progenitors in that KL
was more efficient than FL in promoting survival of CMPBM reconstitution and lineage distribution (Figure 2B).
The studies in primary recipients suggested that the (Table 3).
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The preferential effects of FL on CLP and not CMP
could in part be explained by differences in flt3 expres-
sion. In support of this, 75%–80% of phenotypically de-
fined CLP expressed high levels of flt3 whereas CMP
showed little or no detectable cell surface flt3 expres-
sion, and as previously demonstrated (Adolfsson et al.,
2001) a fraction of cells in the LSK HSC compartment
expressed flt3 (Figure 3A). RT-PCR analysis confirmed
that CLP had approximately 10-fold higher levels of flt3
mRNA expression than CMP (K.T.-M. and E.S., unpub-
lished data).
FL has been demonstrated to be widely expressed,
including in mature blood T cells (Lyman and Jacobsen,
1998). To establish a potential autoregulatory role of FL
in early lymphoid development, we investigated whether
FL might also be expressed in HSC and multipotent
progenitors. Interestingly, RT-PCR analysis demon-
strated FL expression in CLP as well as HSC (LSKflt3),
whereas FL expression in purified CMP was only 5%–
10% relative to CLP (Figure 3B). Only a small fraction
of freshly isolated LSK HSC expressed detectable (by
FACS) cell surface FL, comparable to that of T cells
(Figure 3C). However, as previously demonstrated for T
cells (Chklovskaia et al., 2001), cell surface FL expres-
sion was strongly upregulated on LSK cells following
cytokine activation (Figure 3C).
Discussion
The flt3 receptor was originally identified and character-
ized based on its high level of expression on candidate
HSC in mice (Matthews et al., 1991; Rasko et al., 1995;
Zeigler et al., 1994). Since then, flt3 and its ligand have
been proposed to be important regulators of the HSC
pool (Lyman and Jacobsen, 1998), in particular since
BM cells from flk2-deficient mice are compromised in
multilineage (myeloid and lymphoid) reconstituting abil-
ity (Mackarehtschian et al., 1995). However, the pre-
sent studies clearly demonstrate that the BM of FL-
Figure 3. flt3 Receptor and Ligand Expression within Hematopoieticdeficient mice have normal frequencies of phenotypi-
Stem and Progenitor Cell Compartments
cally (LinSca1kitCD34) and functionally defined
(A) BM stained with antibodies against lineage, flt3, Sca-1, c-kit,long-term HSC. Furthermore, HSC of FL-deficient mice
CD34, IL-7R, and anti-Fc were analyzed by multicolor FACS (Ex-
have normal functional capacities when transplanted perimental Procedures). To investigate flt3 expression on CLP, CMP
into lethally irradiated WT recipients, both with regard to and HSC (LSK) gates were set as indicated in Figure 1. The dotted
reconstitution and self-renewal capacity (as determined lines represent isotype control, and the solid lines represent staining
with anti-flt3 antibody. Plots show representative analysis.through serial transplantation). Rather, we here demon-
(B) Purified HSC (LSKflt3), CLP, and CMP were subjected to globalstrate that the earliest B and T cell committed progeni-
mRNA amplification (Experimental Procedures). Expression levelstors are reduced in FL/ mice, and in line with this,
for each of the populations were calculated relative to levels in theFL/ mice have dramatically reduced levels of the CLP,
population with the highest expression (defined as 100%). Expres-
whereas CMP and other early myeloid progenitors are sion levels represent mean values from two samples of 25 cells after
unaffected (summarized in Figure 4). subtraction of the negative control and normalization against the
These findings are of considerable importance since housekeeping gene 	-actin.
(C) Freshly isolated and in vitro activated CD3 T cells and purifiedthe formation of CMP and CLP is thought to represent
bone marrow LSK cells were investigated for cell surface FL expres-a first and decisive lineage commitment step of HSC
sion by FACS (Experimental Procedures). Plots show FL expression(Akashi et al., 2000a, 2000b; Kondo et al., 1997), and in
within gated CD3 T cell and LinSca1kit cell populations. Thethat regard we here provide evidence for a nonredun-
dotted lines represent isotype controls; the solid lines show staining
dant regulator of CLP generation from HSC. Thus, a main with anti-FL antibody. LSK from FL-deficient mice were used as
function of FL in steady-state hematopoiesis appears to negative control. Plots show representative analysis from one of
be to specifically promote early lymphoid development three experiments with similar results.
from a multipotent progenitor/stem cell population. In
support of this being mediated through a direct rather
Although the mechanism by which FL promotes CLPthan indirect effect of FL, we recently demonstrated
generation, expansion, or maintenance remains to bethat LSKflt3 cells, generated from LSKflt3 HSC, are
immediate precursors of CLP (Adolfsson et al., 2001). established, we here provide evidence that FL efficiently
Regulation of Common Lymphoid Progenitors by flt3
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Figure 4. Hematopoietic Stem and Progeni-
tor Cell Compartments in FL-Deficient Mice
(A) Summary of frequencies of HSC
(LinSca1kitCD34), CLP, and CMP in
bone marrow of WT and FL/ mice. For all
populations, data are expressed as mean
percentages of total cells ( SD) from six an-
imals.
(B) Schematic presentation of the effects of
FL on steady-state hematopoiesis. “Normal”
indicates the same level as WT control; the
arrows indicate reductions.
supports survival of CLP, whereas KL has no such activ- studies with flk2-deficient mice (Mackarehtschian et al.,
1995), remains to be further explored.ity in spite of the CLP also expressing c-kit. However, in
line with its key role in regulating HSC and early myeloid
Experimental Proceduresdevelopment, KL more efficiently promotes survival of
CMP and HSC (Adolfsson et al., 2001).
Animals
As expected, transplantation of WT BM cells into le- Mice genetically deficient in flt3 ligand (FL/) were generated as
thally irradiated FL/ recipients resulted in reduced re- previously described (McKenna et al., 2000) and maintained on a
C57Bl/6 inbred genetic background. Breeding pairs were obtainedgeneration of CLP. However, the reduction in CLP was
from Immunex and were housed at the animal facility at Lund Univer-much less dramatic than in FL/ mice themselves, sug-
sity. FL deficiency was verified by PCR using specific primers (Mc-gesting that the transplanted WT bone marrow cells
Kenna et al., 2000). Eight- to fourteen-week-old (age-matched) micemight express FL and thereby partially compensate for
from the mouse strains FL/ (CD45.2), C57Bl/6 (CD45.2) (WT con-
the FL deficiency. trol), and congenic B6.SJL-PtprcaPepb/BoyJ (CD45.1) were used in
In fact, RT-PCR analysis suggested that purified CLP these experiments. In all transplantation experiments CD45.2 mice
were used as bone marrow donors of test cells while CD45.1 miceas well as LSK HSC themselves express FL constitu-
served as recipients and donors of competitor cells. Mice weretively, whereas CMP express much lower levels. A po-
housed under specific pathogen-free conditions and fed irradiatedtential autocrine role of FL in regulating early lymphoid
food and autoclaved, acidified water.development was further supported by LSK HSC reveal-
ing cell surface expression of FL, in particular following Phenotypic Characterization of Precursors, Progenitors, and
activation. These findings correlated well to known lev- Stem Cells in Hematopoietic Tissues of FL/ Mice
Whereas the BM of flk2-deficient mice have normal cellularity com-els of FL in normal subjects, in which rather low concen-
pared to WT controls (Mackarehtschian et al., 1995), FL-deficienttrations are detected in serum in steady state (100 pg/
mice show slightly reduced (27% reduction) cellularity (McKenna etml) (Lyman et al., 1995) but increase 100-fold when the
al., 2000). In the present studies the focus was to compare thebone marrow is actively regenerating, such as following
relative size of the HSC pool and different progenitor compartments
chemotherapy or irradiation (Chklovskaia et al., 1999, in FL-deficient and WT mice. All phenotypic analysis was performed
2001; Wodnar-Filipowicz et al., 1996). in parallel using tissues from age-matched FL/ and WT control
mice (10 to 14 weeks old). Staining for LinSca1kitCD34 HSCIn conclusion, FL does not play any role in maintaining
was performed as described before (Bryder and Jacobsen, 2000).the HSC pool during steady-state hematopoiesis but
In brief, bone marrow cells were stained with a cocktail of purifiedappears to be critically involved in promoting the earliest
rat anti-mouse lineage (Lin) antibodies: B220 (RA3-6B2), Gr-1 (RB6-lymphoid commitment step from HSC to a CLP. To what
8C5), Mac-1 (M1/70), CD8 (53-6.7), CD5 (53-7.3), CD4 (H129.19),
degree FL might regulate HSC maintenance and/or a and TER-119 (all from PharMingen, San Diego, CA). Lin cells were
reconstitution under conditions distinct from steady- visualized by Tricolor-conjugated goat anti-rat antibody (Caltag Lab-
oratories, Burlingame, CA). Subsequently, cells were washed andstate hematopoiesis, as suggested in reconstitution
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stained with a fluorescein isothiocyanate (FITC)-conjugated rat anti- (Rocky Hill, NJ). Cytokines were used at predetermined optimal
concentrations.mouse CD34 antibody, phycoerythrin (PE)-conjugated rat anti-
mouse Sca-1 antibody, and allophycocyanin (APC)-conjugated rat
anti-mouse c-kit antibody (or isotype-matched control antibodies, Cell Cultures
all from PharMingen). To investigate IL-7R expression on Lin Sorted CLP, CMP, and GMP were seeded in 96-well (U-bottom)
Sca1kit cells, the same cocktail of purified anti-lineage antibodies plates at 50 to 500 cells per well in 200 
l of serum-free medium
was used (visualized by Tricolor-goat anti-rat antibody), together (lymphoid cultures) and in serum-containing medium (myeloid cul-
with directly conjugated anti-B220-CyChrome, anti-CD3-CyChrome tures), both containing 100 U/ml penicillin (BioWhittaker), 100 U/ml
antibodies, anti-Sca1-FITC, anti-c-kit-APC, and biotinylated anti- streptomycin (BioWhittaker), 2 mmol/L L-glutamine (BioWhittaker),
IL-7R (clone A7R34; generously provided by Dr. Koichi Akashi; and 104 mol/L 2-mercaptoethanol (Sigma, St. Louis, MO). The se-
visualized by Streptavidin-PE) antibodies. rum-free medium (X-vivo 15; BioWhittaker) was supplemented with
To identify the CMP, the same Lin staining was performed together 1% detoxified Bovine Serum Albumine (BSA; Stem Cell Technolo-
with directly conjugated anti-B220-CyChrome and anti-CD3- gies Inc.). The serum-containing medium (IMDM, BioWhittaker), was
CyChrome, anti-c-kit-APC, anti-CD34-FITC and anti-Fc-PE (Phar- supplemented with 20% FCS (BioWhittaker). The following growth
Mingen) antibodies, and anti-Sca-1-Biotin and anti-IL-7R antibod- factors were used: KLFLIL-7 for lymphoid development and
ies (visualized by Streptavidin-CyChrome). To characterize B cell KLGM-CSFG-SCFIL-3CSF-1TpoEpo for myeloid devel-
progenitors in BM (Hardy et al., 1991), cells were incubated with opment. Cell numbers were counted after 11 days of culture at 37C
directly conjugated antibodies: anti-B220-APC, anti-IgM-FITC, and and 5% of CO2 in air, and cell phenotypes were evaluated by flow
anti-CD43-PE (PharMingen). To study T cell progenitors, thymocytes cytometry using monoclonal antibodies for B cell (B220, CD19) and
were stained with directly conjugated anti-CD25-PE, anti-CD4-FITC, myeloid (Gr-1, Mac-1) lineages (all from PharMingen).
anti-CD8-FITC, anti-B220-FITC, anti-Gr-1-FITC, anti-Mac-1-FITC,
and anti-CD44-Biotin (clone IM7, generously provided by Karin Pe- In Vitro Indirect Viability Assay; Delayed Addition Studies
tersson, Department of Immunology, University of Lund) (visualized As described elsewhere (Borge et al., 1996), because heterogeneity
by Streptavidin-APC, PharMingen) antibodies. 7-AAD (Sigma, remains a limitation in studies of phenotypically defined progenitor
St.Louis, MO) was included in all stainings to exclude dead cells. and stem cell populations, a functionally based delayed addition
Stained cells were analyzed on a FACSCalibur using CellQuest (Bec- assay remains the most reliable viability assay for primitive progeni-
ton Dickinson, San Jose, CA) software. FlowJo software (Tree Star, tors. Fifty to one hundred CLP were seeded in 96-well (U-bottom)
Inc., San Carlos, CA) was used for analysis. plates in 200 
l serum-free medium (see above) supplemented with
FL or KL, or without any growth factors. The cells were preincubated
for 40 hr at 37C and 5% of CO2 in air before the addition ofPurification of Progenitor Cells
KLFLIL-7 into each well. Following an additional 11 days of cul-
All cell isolations were performed by an immunomagnetic-based
ture at 37C and 5% of CO2, cell numbers were counted, and cellpreenrichment followed by multicolor flow cytometric stainings as
phenotypes were evaluated by flow cytometry (as described above).
described before (Adolfsson et al., 2001; Bryder and Jacobsen,
Sorted CMP were seeded in Terasaki plates at a concentration
2000). Cells were sorted on a FACS Vantage Cell Sorter (Becton
of one cell per well in 10 
l IMDM20% FCS (BioWhittaker) supple-
Dickinson, San Jose, CA), equipped with a 488 nm argon and a 633
mented with KL or FL, or without any growth factors. Cells were
nm He-Ne laser, at a rate of 2000–8000 cells per second using a
preincubated for 6 days before a cocktail of growth factors was
double sorting strategy. In brief, lineage-depleted (Lin) cells were
added (KLGM-CSFG-SCFIL-3CSF-1TpoEpo). Wells were
isolated on a magnetic particle concentrator (MPC-6, Dynal, Oslo,
scored for cell growth (greater than three cells) after an additional
Norway) after incubation of BM cells with a cocktail of purified
11 days of incubation.
lineage (Lin) antibodies (B220 [RA3-6B2], Gr-1 [RB6-8C5], Mac-1
[M1/70], CD8 [53-6.7], CD5 [53-7.3], CD4 [H129.19], and TER-119
In Vivo Reconstitution Experiments[all rat anti-mouse from PharMingen]) and subsequent incubation
Transplantation experiments were conducted following approvalwith sheep anti-rat IgG (Fc)-conjugated immunomagnetic beads
from the local ethics committee. Lethally irradiated (950 rad) CD45.1(Dynal, Oslo, Norway).
mice were injected intravenously with 1  106 BM cells isolatedTo purify CLP, Lin cells were stained using the same strategy
from tibiae and femora from FL/ or WT control mice (CD45.2).as that used for phenotypic analysis (see above) and as previously
Mice were cotransplanted with 1  106 BM cells from CD45.1 micedescribed (Akashi et al., 2000b; Kondo et al., 1997). An enrichment
to allow quantification of reconstituting ability and to ensure survival,sort of IL-7R cells (triggering on the same parameter) was first
and kept in individually ventilated cages throughout the experimentperformed, followed by a normal-R mode sort on all parameters
under pathogen-free conditions. Primary recipient mice were ana-(LinIL-7RSca1lowkitlow).
lyzed for the presence of donor-type reconstitution at 4–6 and 16–18To purify CMP and GMP, Lin cells were stained with purified
weeks after transplantation. Serial transplantation was performedanti-IL-7R (clone A7R34; visualized by goat anti-rat PE), biotinyl-
by pooling BM from primary recipients 18 weeks posttransplantationated anti-Sca-1 (visualized by Streptavidin-APC), and anti-CD34-
and injecting one femur equivalent (FE) into each new lethally irradi-FITC antibodies (all from PharMingen). An enrichment sort was per-
ated secondary CD45.1 recipient. Analysis of secondary recipientsformed for CD34 cells (triggering on the same parameter). Next,
was performed 3 months after secondary transplantation.cells were sorted based on the CD34Sca1LinIL-7Rphenotype.
To evaluate the ability of FL-deficient mice to reconstitute CLPFinally, sorted cells were restained using anti-Fc-PE and anti-
and HSC, lethally irradiated recipient CD45.2 (WT or FL/) micec-kit-APC antibodies (PharMingen) and sorted based on the
were transplanted with 5 106 unfractionated BM cells from CD45.1kitCD34Fclow phenotype for CMP and the kitCD34Fchigh phe-
WT donor mice. Four weeks after transplantation bone marrow cellsnotype for GMP. The purity of all sorted progenitor populations
were isolated from tibiae and femora and the frequency of donor-was 95%.
derived (CD45.1) cells with HSC (LinSca1kit), CLP (LinIL-
7RSca1lowkitlow), and CMP (LinSca1kitCD34Fclow) pheno-
types were analyzed by flow cytometry. To exclude recipient cells,Hematopoietic Growth Factors
an anti-CD45.2-CyChrome antibody was combined with the lineageRecombinant human (rh) interleukin-7 was generously provided by
staining.Dr. Natalio Vita, Sanofi Elf (Montpellier, France). Rh thrombopoietin
(Tpo), rh granulocyte colony-stimulating factor (G-CSF), and recom-
binant murine (rm) granulocyte-macrophage colony-stimulating fac- Blood and Bone Marrow Analysis of Reconstituted Mice
Peripheral blood (PB) was collected from the retro-orbital sinustor (GM-CSF) were generously provided by Amgen Corp. (Thousand
Oaks, CA). Rm mast cell growth factor (c-kit ligand; KL) and rh fms- venous plexus. PB cells were stained with antibodies against CD45.1
and CD45.2 to determine the level of reconstitution. To determinelike tyrosine kinase-3 ligand (Flt3L; FL) were kind gifts from Immunex
(Seattle, WA). Rh colony-stimulating factor 1 (CSF-1) was from the reconstitution of different lineages, PB or BM cells were stained
for the expression of Gr-1/Mac-1 (myeloid cells), B220 (B cells),Chiron (Emeryville, CA), and rm interleukin-3 from PeproTech Inc.
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and CD3 (T cells) as well as CD45.1 and CD45.2 (PharMingen). All Health Grant), the John and Augusta Perssons Foundation, the Med-
ical Faculty of Lund University, the Royal Physiographic Society inacquisitions were performed on a FACSCalibur (Becton Dickinson).
Lund, the Swedish Cancer Society, the Swedish Foundation for
Strategic Research, the Swedish Medical Research Council, theCell Surface flt3 Receptor and Ligand Expression Analysis
Swedish Pediatric Cancer Society, the Thelma Zoegas Foundation,Cell surface flt3 expression on CLP and LSK HSC cell populations
and the Tobias Foundation. E.S. is a senior scientist supported bywas investigated by five-color FACS analysis. Lineage antigens were
the Swedish Gene Therapy Program.visualized as described above as well as with directly conjugated
anti-B220-CyChrome and anti-CD3-CyChrome antibodies. In addi-
tion, cells were stained with anti-c-kit-APC, anti-Sca-1-FITC, anti- Received: December 26, 2001
Flt3-PE (PharMingen), and anti-IL-7R-Biotin (visualized by Strep- Revised: August 30, 2002
tavidin-R613, Sigma) antibodies. Flt3 expression on CLP and LSK
populations was established using the same gate settings as de- References
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